The influence of the intestinal microflora to the efficacy of Rosuvastatin
Abstract Background Intestinal microflora has been shown to play essential roles in the clinical therapies of metabolic diseases. The present study is aiming to investigate the potential roles and mechanisms of how intestinal microflora mediates lipid-reduction efficacy of Rosuvastatin. Methods To i...
Main Authors: | Lijun Wang, Yang Wang, Hongwei Wang, Xue Zhou, Xianjing Wei, Zezhou Xie, Zhipeng Zhang, Keke Wang, Jianjun Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-018-0801-x |
Similar Items
-
Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study
by: Toivo Laks, et al.
Published: (2008-12-01) -
Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy
by: I. A. Alekseeva, et al.
Published: (2020-10-01) -
Fixeddose combination of rosuvastatin + ezetimibe: ease of use, safety and efficacy
by: I. A. Alekseeva, et al.
Published: (2019-10-01) -
Possibilities of using rosuvastatin to achieve target level of low-density lipoprotein cholesterol in clinical practice
by: Yuliia A. Prus, et al.
Published: (2020-03-01) -
Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)